Evaluation and implementation of new MRI techniques in the clinical routine of pediatric whole body imaging

Not Applicable

Recruiting

• Conditions: various tumor diseases; C00-C97; C81; C91; C40; C41; Malignant neoplasms; Hodgkin lymphoma; Lymphoid leukaemia; Malignant neoplasm of bone and articular cartilage of limbs

• Registration Number: DRKS00020462
• Lead Sponsor: niversitätsklinikum Tübingen, Radiologische Klinik, Abt. für Diagnostische & Interventionelle Radiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Male and female patients >7 years - 40 years,
transfer from pediatrics with a clinical indication for a (contrast-enhanced) MRI examination (Early detection or a follow-up check as standard of care of an oncological disease,
all necessary laboratory parameters (creatinine / GFR according to UKT's internal guidelines) are available,
no need for anesthesia for the examination,
written consent to the study of the patient (depending on the level of development) and the legal guardian.

Exclusion Criteria

all MR-relevant exclusion criteria,
all contrast medium-relevant exclusion criteria,
the need for anesthesia for the examination,
non-compliance of the patients for an MRI examination and a study-related extension of the examination time.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Qualitative and quantitative comparison between the newly implemented MR sequences compared to the MR standard protocol based on various criteria (resolution of certain anatomical structures and detection of benign and malignant lesions, exemplary focal bone lesions) for evaluating the image quality, sensitivity and specificity in the detection of malignant lesions.<br><br>

Secondary Outcome Measures

Name	Time	Method
Determination of movement artifacts occurring in new vs. MR sequences used as standard.<br>Determination of the potential time saving by using new MR sequences.